期刊文献+

右美托咪定用于老年患者经皮椎体后凸成形术的镇痛效果 被引量:21

Effect of dexmedetomidine on analgesia in elderly patients undergoing percutaneous kyphoplasty surgery
下载PDF
导出
摘要 目的观察右美托咪定用于局麻经皮椎体后凸成形术(PKP)中的镇痛效果和对血流动力学的影响。方法择期行PKP手术老年患者80例,年龄61~82岁,随机均分为两组。D组于手术开始前持续泵注右美托咪定负荷剂量1.0μg/kg,10min泵完,后以0.5μg·kg-1·h-1维持至手术结束。C组泵注等量生理盐水。两组均用1.0%的利多卡因局部浸润麻醉,总量为30~40ml。观察患者给药后即刻(T0)、注入局麻药时(T1)、穿刺针到达椎体时(T2)、骨水泥注入时(T3)、手术结束时(T4)的MAP、HR和疼痛VAS评分。结果与C组比较,T1~T4时D组VAS评分、MAP明显降低(P<0.05),HR明显减慢(P<0.05)。与T0时比较,T1~T4时D组MAP明显降低,HR明显减慢(P<0.05);而C组MAP明显升高,HR明显增快(P<0.05)。结论右美托咪定清醒镇痛可为PKP提供较为满意的镇痛效果,降低围术期血流动力学反应。 Objective To observe the analgesic effect of dexmedetornidine and its influence on hemodynamics in patients undergoing percutaneous kyphoplasty (PKP) surgery. Methods Eighty patients undergoing PKP surgeries aged 61-82 years were randomly divided into dexmedetomidine group (group D) and the control group (group C) for 40 cases each. Group D received loading dose of intravenous infusion of dexmedetomidine 1.0 ~g/kg for 10 min, and then maintained at 0.5μg.kg-1. h-1. Group C received equivalent volume of saline. The MAP and HR were recorded at administration of immediate (To), injection of local anesthetics(Tx ), a puncture needle to vertebral body (T2), bone cement injection (T3),the end of operation (T4),the VAS scores were assessed at T0-T4. Results Patients in the group D had lower VAS scores than those of the group C at T1-T4. At T1-T4, MAP in group D decreased significantly, HR decreased significantly (P〈0. 05) ;MAP in group C increased obviously, HR increased obviously (P〈0. 05). Conclusion Dexmedetomidine can provide effective analgesia for patients undergoing PKP surgery reduce the perioperative hemodynamic response during operation.
出处 《临床麻醉学杂志》 CAS CSCD 北大核心 2013年第4期353-355,共3页 Journal of Clinical Anesthesiology
关键词 右美托咪定 镇痛 经皮椎体后凸成形术 Dexmedetomidine Analgesia Percutaneous kyphoplasty
  • 相关文献

参考文献5

二级参考文献50

  • 1李民,张利萍,吴新民.右美托咪啶在临床麻醉中应用的研究进展[J].中国临床药理学杂志,2007,23(6):466-470. 被引量:483
  • 2佘守章,李慧玲,许学兵,莫世湟.右旋美托咪啶的镇静效应及其对全麻镇静深度的影响[J].临床麻醉学杂志,2006,22(1):10-12. 被引量:105
  • 3[1]Khan ZP,Ferguson CN,Jones RM.Alpha-2 and imidazoline receptor agonists:their pharmacology and therapeutic role[J].Anesthesia,1999;54:146-165.
  • 4[2]Kamibayashi T,Maze M.Clinical uses of alpha 2-adrenergic agonists[J].Anesthesiology,2000;93:1345-1350.
  • 5[3]Calzada BC,De Artinano AA.[alpha]2-Adrenoreceptor subtypes[J].Pharmacol Res,2001;44:195-208.
  • 6[4]Hunter JC,Fontanna DJ,Hedley LR,et al.Assessment of the role of alpha 2-adrenoceptor subtypes in the antinociceptive,sedative and hypothermic action of dexmedetomidine in transgenic mice[J].Br J Pharmacol,1997;122:1339-1344.
  • 7[5]Nelson LE,Lu J,Guo TZ,et al.The α2-Adrenoceptor agonist dexmedetomidine converges on an endogenous sleep-promoting pathway to exert its sedative effects[J].Anesthesiology,2003;98:428-436.
  • 8[6]Coull JT,Jones M,Egan T,et al.Attentionla effects of noradranaline vary with arousal level:selective activation of thalamie pulvinar in humans[J].Neuro Image,2004;22:315-322.
  • 9[7]Eisenach JC.[Alpha]2 agonists and analgesia[J].Exp Opin Invest Drugs,1994;3:1005-1010.
  • 10[8]Ma D,Rajakumamswamy N,Maze M.Alpha2-Adrenoceptor agonists:shedding light on neuroprotection?[J].Br Med Bull,2005;71:77-92.

共引文献506

同被引文献172

引证文献21

二级引证文献85

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部